Clinical trial

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis

NCT00751881

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-08-01

PhasePHASE3

Study timeline

Study start (unknown)2008-08-01Date precision: month

Registry last updated2016-07-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

PlaceboDRUG

TeriflunomideDRUG · verified · RxNorm: teriflunomide

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

BeijingChina9 IstanbulTurkey (Türkiye)4 StockholmSweden3 PhiladelphiaPennsylvania, United States2 ShanghaiChina2 GuangzhouChina2 KharkivUkraine2 BratislavaSlovakia2 SantiagoChile2 TianjinChina2 NanjingChina2 LvivUkraine2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00751881 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.